Virtus LifeSci Biotech Cl... (BBC)

NYSEArca: BBC · Precio en tiempo real · USD

53.81

+0.55 (1.03%)

Al cierre: Aug 18, 2026, 3:59 PM

1.03% (1D)

Precio de compra	n/a
Capitalización de mercado	n/a
Ingresos (TTM)	n/a
Beneficio neto (TTM)	n/a
Beta	n/a
EPS (TTM)	n/a
Ratio PER (TTM)	n/a
Adelante PE	n/a
P/B (TTM)	n/a
P/S (TTM)	n/a
Earnings Date	n/a

Precio de venta	83.97
Volumen	6,708
Volumen medio (20D)	22,956
Abierto	53.47
Anterior Cerrar	53.26
Rango del día	53.18 - 53.81
Rango de 52 semanas	21.83 - 54.95
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de BBC

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval....

[Leer más]

Industria n/a

Sector n/a

IPO Fecha Dec 17, 2014

Empleados n/a

Bolsa de Valores NYSEArca

Símbolo bursátil BBC

Perfil completo de la empresa

Desempeño financiero

En undefined, los ingresos de Virtus LifeSci Biotech Clinical Trials ETF fueron n/a, un aumento de undefined% en comparación con n/a del año anterior. Las ganancias fueron n/a, un aumento de undefined%.

Estados financieros

Noticias

3 semanas hace · MarketBeat

Innovative ETF Strategies That Are Paying Off This Summer

Amid record ETF inflows, niche funds like BBC, LATR, and FMED offer targeted exposure to biotech trials, buy-now-pay-later firms, and disruptive medicine, with notable recent returns.